Nasdaq · CIK 0001860871
TVGN Tevogen Bio Holdings Inc.
Insider trading from SEC Form 4. Last filing 27 d ago. Close $6.68 on Oct 12, 2026, +72% from the 52-week low and -82% from the high.
In brief
Tevogen Bio Holdings Inc. (TVGN) has 33 SEC Form 4 filings on file from 9 insiders, the latest filed on Sep 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
6 open-market trades have been scored at TVGN. The newest: Neal Flomenberg (See Remarks) sold $6,635 of stock on Mar 10, 2026, filed Mar 17, 2026, scored 15 (weak). The largest of the 6 shown: Ryan H. Saadi (Chief Executive Officer) sold $1.8M on Jun 9, 2025, scored 50 (moderate).
3 Form 144 notices of planned sales are on file, the latest filed Feb 6, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Tevogen Bio Holdings Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Neal Flomenberg See Remarks sell | $6,635 972 shares | -1% | +7% from low-89% from high | |
| 50Moderate | Ryan H. Saadi Chief Executive Officer sell | $1.8M 1,438,206 shares | -1% | +325% from low-64% from high | |
| 28Weak | Neal Flomenberg See Remarks sell | $254k 232,968 shares | -6% | - | |
| 28Weak | Neal Flomenberg See Remarks sell | $232k 211,909 shares | -5% | - | |
| 28Weak | Neal Flomenberg See Remarks sell | $250k 213,817 shares | -5% | - | |
| 45Moderate | Neal Flomenberg See Remarks sell | $1.7M 1,078,600 shares | -20% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 6, 2026 | Desai Kirti Officer | 330,000 0.17% of outstanding | $103k | Feb 6, 2026 | $5,117 |
| Dec 30, 2025 | Desai Kirti Officer | 15,500 0.01% of outstanding | $6,149 | Dec 30, 2025 | none |
| Jun 9, 2025 | Saadi Ryan H. Officer, Director, 10% Stockholder | 1,438,206 0.78% of outstanding | $1.6M | Jun 9, 2025 | none |
Transactions
Every row filed, 40 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Ryan H. Saadi Chief Executive Officer | AGrant or award Common Stock | +8,000,000 | $0.00 | $0 | 11,705,689 | 27 d ago |
| Sep 14, 2026 | Kirti Desai Chief Financial Officer | AGrant or award Common Stock | +750,000 | $0.00 | $0 | 992,983 | 27 d ago |
| Sep 11, 2026 | Keow Lin Goh director | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 123,678 | 28 d ago |
| Sep 11, 2026 | Susan M Podlogar director | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 123,678 | 28 d ago |
| Sep 11, 2026 | Curtis L. Patton director | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 139,192 | 28 d ago |
| Sep 11, 2026 | Victor J. Sordillo director | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 126,539 | 28 d ago |
| Sep 11, 2026 | Jeffrey L. Feike director | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 131,435 | 28 d ago |
| Jul 10, 2026 | Curtis L. Patton director | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 64,192 | Jul 10, 2026 |
| Jul 10, 2026 | Victor J. Sordillo director | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 51,539 | Jul 10, 2026 |
| Jul 10, 2026 | Ryan H. Saadi Chief Executive Officer | AGrant or award Common Stock | +1,220,000 | $0.00 | $0 | 3,705,689 | Jul 10, 2026 |
| Jul 10, 2026 | Susan M Podlogar director | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 48,678 | Jul 10, 2026 |
| Jul 10, 2026 | Keow Lin Goh director | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 48,678 | Jul 10, 2026 |
| Jul 10, 2026 | Jeffrey L. Feike director | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 56,435 | Jul 10, 2026 |
| Jul 10, 2026 | Kirti Desai Chief Financial Officer | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 242,983 | Jul 10, 2026 |
| Mar 10, 2026 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -19 | $7.75 | $147 | 77,893 | Mar 17, 2026 |
| Mar 11, 2026 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -452 | $7.26 | $3,282 | 77,441 | Mar 17, 2026 |
| Mar 13, 2026 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -501 | $6.40 | $3,206 | 76,940 | Mar 17, 2026 |
| Dec 18, 2025 | Ryan H. Saadi Chief Executive Officer | GGift Common Stock | -50,000 | $0.00 | $0 | 124,284,453 | Dec 22, 2025 |
| Dec 11, 2025 | Kirti Desai Chief Financial Officer | GGift Common Stock | -300,000 | $0.00 | $0 | 10,149,186 | Dec 15, 2025 |
| Dec 11, 2025 | Ryan H. Saadi Chief Executive Officer | GGift Common Stock | -460,000 | $0.00 | $0 | 124,334,453 | Dec 12, 2025 |
| Aug 15, 2025 | Ryan H. Saadi Chief Executive Officer | GGift Common Stock | -20,000 | $0.00 | $0 | 124,794,453 | Aug 18, 2025 |
| Jun 27, 2025 | Neal Flomenberg See Remarks | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 3,895,608 | Jul 1, 2025 |
| Jun 27, 2025 | Sadiq Khan Chief Commercial Officer | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 1,169,618 | Jul 1, 2025 |
| Jun 27, 2025 | Ryan H. Saadi Chief Executive Officer | AGrant or award Common Stock | +8,000,000 | $0.00 | $0 | 124,814,453 | Jul 1, 2025 |
| Jun 27, 2025 | Kirti Desai Chief Financial Officer | AGrant or award Common Stock | +750,000 | $0.00 | $0 | 10,449,186 | Jul 1, 2025 |
| Jun 9, 2025 | Ryan H. Saadi Chief Executive Officer | SOpen-market sale Common Stock | -1,438,206 | $1.23 | $1.8M | 116,814,453 | Jun 9, 2025 |
| Mar 12, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -232,968 | $1.09 | $254k | 3,595,608 | Mar 14, 2025 |
| Mar 7, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -71,273 | $1.14 | $81k | 3,969,212 | Mar 11, 2025 |
| Mar 10, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -70,384 | $1.09 | $77k | 3,898,828 | Mar 11, 2025 |
| Mar 11, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -70,252 | $1.05 | $74k | 3,828,576 | Mar 11, 2025 |
| Mar 4, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -14,639 | $1.28 | $19k | 4,239,663 | Mar 6, 2025 |
| Mar 5, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -110,659 | $1.21 | $134k | 4,129,004 | Mar 6, 2025 |
| Mar 6, 2025 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -88,519 | $1.10 | $97k | 4,040,485 | Mar 6, 2025 |
| Dec 23, 2024 | Jeffrey L. Feike director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 821,771 | Dec 26, 2024 |
| Dec 23, 2024 | Keow Lin Goh director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 433,923 | Dec 26, 2024 |
| Dec 23, 2024 | Susan M Podlogar director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 433,923 | Dec 26, 2024 |
| Dec 23, 2024 | Curtis L. Patton director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 1,209,618 | Dec 26, 2024 |
| Dec 23, 2024 | Victor J. Sordillo director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 336,962 | Dec 26, 2024 |
| Dec 23, 2024 | Victor J. Sordillo director | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 576,962 | Dec 26, 2024 |
| Oct 17, 2024 | Neal Flomenberg See Remarks | SOpen-market sale Common Stock | -1,078,600 | $1.62 | $1.7M | 4,254,302 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kirti DesaiChief Financial Officer
- Jeffrey L. Feikedirector
- Neal FlomenbergSee Remarks
- Keow Lin Gohdirector
- Sadiq KhanChief Commercial Officer
- Susan M Podlogardirector
- Curtis L. Pattondirector
- Ryan H. SaadiChief Executive Officer
- Victor J. Sordillodirector
Questions about TVGN
Answered from the filings on this page, as of the latest one.
Are insiders buying TVGN?
No. In the last 90 days no insider at Tevogen Bio Holdings Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TVGN on the open market?
Neal Flomenberg (See Remarks) sold $6,635 of TVGN on Mar 10, 2026 and filed the Form 4 on Mar 17, 2026. InsiderTell scored 15 (weak).
How many insiders file Form 4 at Tevogen Bio Holdings Inc.?
9 people have filed a Form 4 at Tevogen Bio Holdings Inc., among them Kirti Desai (Chief Financial Officer), Jeffrey L. Feike (director), Neal Flomenberg (See Remarks). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.